Skip to the main content.
HUB of
Biotherapeutic
Intelligence™
Antibody Discovery Services
Overview
Target Analysis & Immunization
Antibody Discovery & Characterization
Developability Profiling
Optimization & Engineering
Preclinical Services
Protein Manufacturing
Overview

 

Catalog Products
Online Store
HUB of
Biotherapeutic
Intelligence™
AI Technology
LENSai Applications
The LENSai Difference
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Applications
Insights
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Resources
Antibody Discovery Resources
AI Technology Resources
IPA Collective
Resource Spotlight
See our latest upcoming event.
Tell me moreto Events
HUB of
Biotherapeutic
Intelligence™
Company
Overview
Leadership
Investor Relations
Careers
Locations
Contact Us
News
News & Press Releases
Events
See our latest upcoming event.
Tell me moreto Events

Antibody Discovery Resources

IPA COLLECTIVE

What is the IPA Collective? It is forum designed for the sharpest minds in the industry. This is an exclusive opportunity to connect with industry leaders, celebrate cutting-edge advancements, and engage in thought-provoking discussions about emerging trends.  Learn More  icon blue arrow

Case Studies

Spotlight
Generating sequence and functional diversity in transgenics
Generating sequence and functional diversity in transgenics
icon blue arrow
A case for genetic immunization
A case for genetic immunization
icon blue arrow
MHC I: A multi-cohort hybridoma workflow used to produce clinically relevant monoclonal antibodies
MHC I: A multi-cohort hybridoma workflow used to produce clinically relevant monoclonal antibodies
icon blue arrow
Developing highly specific mAb's – targeting post-translational modifications using Rabbit B cell Select
Developing highly specific mAb's – targeting post-translational modifications using Rabbit B cell Select
icon blue arrow
See All icon blue arrow

Posters

Spotlight
Bispecific antibody discovery and characterization: from discovery through production<br> 
Bispecific antibody discovery and characterization: from discovery through production
 
icon blue arrow
Humanization: rabbit mAb CDR grafting, the first step towards clinically suitable monoclonal antibodies
Humanization: rabbit mAb CDR grafting, the first step towards clinically suitable monoclonal antibodies
icon blue arrow

Webinars

Spotlight
Staying Ahead of the Virus

Presenter: Dr. Ilse Roodink

Moderator: Dr. Debby Kruijsen

Discussing How to Combat SARS-CoV-2

Presenter: Dr. Ilse Roodink

High-throughput identification of genetically distinct, target-specific antibodies

Presenter: Dr. Ilse Roodink

Optimization of Antibodies Against Multipass Membrane Proteins

Presenter: Dr. Ilse Roodink

Moderator: Dr. Debby Kruijsen

Presentations

Anti-idiotype antibodies – the superiority of Rabbit B cell Select
Anti-idiotype antibodies – the superiority of Rabbit B cell Select
icon blue arrow

White Papers

icon notes

Transcript: Optimizing antibody discovery strategy for clinical success of next-gen immuno-oncology therapeutics

icon blue arrow